Physician profile
John C Collins
NPI 1689659559
$4,292.65
in general payments reported to CMS, 2019-2025
41 companies · $570 in 2025
The $570 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $428 · 2021: $1,171 · 2022: $640 · 2023: $876 · 2024: $358 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707 · Education: $96.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.50 |
| Education | $96.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $643.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $571.53 | 2020-2025 | Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $278.67 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Teva Pharmaceuticals USA, INC. | $250.74 | 2019-2024 | Austedo Xr, Austedo |
| Supernus Pharmaceuticals, INC. | $213.40 | 2021-2023 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $200.87 | 2019-2025 | Rexulti |
| Amgen INC. | $167.13 | 2019-2024 | Evenity, Prolia, Krystexxa |
| Pfizer INC. | $166.55 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $145.41 | 2019-2021 | |
| Alkermes, INC. | $134.26 | 2021-2024 | Lybalvi, Vivitrol |
| Allergan, INC. | $120.28 | 2020 | |
| Grifols USA, LLC | $115.02 | 2019-2025 | Prolastin-C Liquid |
| Abbott Laboratories | $113.70 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Neurocrine Biosciences, INC. | $111.69 | 2021-2023 | Ingrezza |
| Dexcom, INC. | $107.69 | 2022-2025 | Dexcom G6 Transmitter |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.